Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis - Test2 - elhamkhani - TriplyDB

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

http://www.wikidata.org/entity/Q29619873

about

miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis Inhibition of microRNA function by antimiR oligonucleotides Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes miRNA studies in in vitro and in vivo activated hepatic stellate cells Circulating microRNAs are new and sensitive biomarkers of myocardial infarction MicroRNA dysregulation in diabetic ischemic heart failure patients Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice MicroRNA-218 regulates vascular patterning by modulation of Slit-Robo signaling MicroRNAs: new players in cardiac injury and protection MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20 The Role of p38 MAPK in the Development of Diabetic Cardiomyopathy Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and Apoptosis Epigenetics in heart failure phenotypes Resveratrol and Cardiovascular Diseases Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction Epigenetic associations in relation to cardiovascular prevention and therapeutics Role of Noncoding RNAs as Biomarker and Therapeutic Targets for Liver Fibrosis Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes Epigenetic regulation in cardiac fibrosis Emerging Roles for MicroRNAs in Perioperative Medicine Role and Function of MicroRNAs in Extracellular Vesicles in Cardiovascular Biology The role of microRNAs in bone remodeling miRNA therapeutics in cardiovascular diseases: promises and problems MicroRNAs: Novel Players in Aortic Aneurysm Update on the Pathogenic Implications and Clinical Potential of microRNAs in Cardiac Disease Aerobic exercise training promotes physiological cardiac remodeling involving a set of microRNAs The function of miRNA in cardiac hypertrophy Potential role of dipeptidyl peptidase IV in the pathophysiology of heart failure TGF-β/Smad signaling in renal fibrosis Good and bad sides of TGFβ-signaling in myocardial infarction Recent developments in myofibroblast biology: paradigms for connective tissue remodeling The two faces of miR-29 Non-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and Disease

P2860

Q21092446-F6727436-391A-407D-87DD-02C21D5E5E45 Q21135329-B15E2575-7AC9-441D-8749-4F89B0BA50ED Q21198757-422FB90F-837A-44E9-8B07-712D4F889374 Q24303139-A1A70465-EAF3-4C79-B1BF-56366A65D7AF Q24305799-B2621761-49D2-4C17-9B70-FE1F1A99F75D Q24598242-D17DD960-1A6E-480B-84C4-0BF51C850B84 Q24604386-E035A7D1-94F0-4A87-A73A-9F0462C911AE Q24606657-094337EC-43FA-46F3-B3B9-95461AF39635 Q24606701-65085172-AE27-4F34-A4CA-4D523DBD37D0 Q24618462-113142B3-7B33-4F3D-94FD-AAADF72D4DB1 Q24623247-BB18AEA0-C417-494C-A9FD-1FEEAFE5F06C Q24630924-1855E066-B7D2-4C0E-A419-193E4D88BAD5 Q24635236-742A3D90-3676-4F71-8D4A-E3552D7942AE Q24647407-81CB5174-1DF2-4DD2-B3BD-7DB79E770F89 Q24648242-10CD7AD0-1B49-46AD-85DE-DB66CE7415C6 Q24651483-7786B186-975C-4062-A77A-AA5B3EE9998F Q26744743-9DE4AB31-D104-44D0-B1E7-F430575277FC Q26746063-A3271D85-87A9-4BF1-A7D7-DD23CBAE91FD Q26746965-03F99FE6-06F1-426B-90F4-A81964BC5AAB Q26747565-ACF24573-A441-4180-8E42-B17C862ED662 Q26752801-9D6D6A44-0162-4F07-A8D4-B34CE246C432 Q26771125-27C0AB84-8EE3-4885-B22C-FB38B4FFD97F Q26771428-1CE3595A-D14D-4D94-A056-CDD499EB040B Q26774309-2890BFA5-CF3A-4962-9C35-BFEA20F1E0CC Q26774376-8AA37A3E-C9ED-4ECA-8805-BD71F59BDBBD Q26774536-72A36D72-674C-4D0C-B1B0-408E7507DFF4 Q26775176-4488BC43-037D-4B26-8584-B392A28D40E8 Q26777595-C406C245-CF2F-4CF1-A706-B0C52C05B6F1 Q26799815-D6D687EC-2F18-4A5C-B148-F6C1062B78F4 Q26801614-622E60AF-6F16-4638-AF8C-7B20BBF79D9D Q26801877-1EE713B3-D7FF-4CF7-9F0E-B27A83635F0D Q26801907-4260C9BB-822C-41AF-8786-DDD00761FA50 Q26827482-CEF798A0-DAC1-430A-B555-62FF952AD925 Q26828961-01DFACA4-456F-41A9-BC82-2058955C60EC Q26829634-2B081AD9-48BA-4773-945D-FAB5813A2323 Q26851198-2CE80A7E-E1E4-4497-B8F7-E89C292A5CDD Q26863465-1963E408-B606-41CD-82FA-6C7592DDDA92 Q26863751-68492F65-634B-495A-BF28-246A51688A3E Q26996481-97F99190-A15E-4E68-B303-7B531DE4E236 Q26999363-2E621E18-4E44-4483-937A-F45694D73D84

P2860

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

http://www.wikidata.org/entity/Q29619873

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Dysregulation of microRNAs aft ...... of miR-29 in cardiac fibrosis

@ast

Dysregulation of microRNAs aft ...... of miR-29 in cardiac fibrosis

@en

type

label

Dysregulation of microRNAs aft ...... of miR-29 in cardiac fibrosis

@ast

Dysregulation of microRNAs aft ...... of miR-29 in cardiac fibrosis

@en

prefLabel

Dysregulation of microRNAs aft ...... of miR-29 in cardiac fibrosis

@ast

Dysregulation of microRNAs aft ...... of miR-29 in cardiac fibrosis

@en

P1433

Q29619873-A9D36032-27CA-4AD6-BE72-4AA5B845655B

P1476

Q29619873-78A5BA99-FFCA-47CF-B868-B7869F85E54E

P2093

Q29619873-04262849-6940-4F56-8ACA-E9D101EB50E1

Q29619873-3420A74A-E67B-453B-B592-5129A204AD08

Q29619873-3EF40074-ED59-44BD-9994-25BDFFB37A8E

Q29619873-68F0195C-341A-4519-B400-0A79D0C9DD52

Q29619873-792BD1FE-0516-4E86-B2B5-BCF0F39FF133

Q29619873-81456428-17AE-4734-9DF9-328F4B4E92BB

Q29619873-D52747C2-8044-4A66-A7EA-B6FA68AB12B2

Q29619873-DB7A2A4B-2072-4DEC-9707-87B75D5E12B6

P2860

Q29619873-0B1811A4-2B3D-4CC3-BD8C-58641D2A62B7

Q29619873-1C965B02-8F79-45C6-B399-31891422ECB7

Q29619873-453EAAAE-E334-4D5E-A3FD-D4A3580530D0

Q29619873-48188CDD-50E1-402B-9DEA-9E35A46CF22F

Q29619873-4B773D0A-99B7-4894-853F-BFCD4D1FDCFB

Q29619873-4CE90AAC-AB12-41D8-9A08-6CCB9CEC7655

Q29619873-61DF4173-6957-41FA-8EEB-8931EFC14685

Q29619873-75A082FD-0437-40D2-87FE-FD9B20B2AA55

Q29619873-81524BA0-BE8F-4DB2-85A2-F1600009144B

Q29619873-8BCE8BAC-8D06-4701-92B7-2B1CFC332AAC

P304

Q29619873-57E13337-CB42-4588-830B-003EEFDDAF37

P31

Q29619873-ECE16E24-3B68-436B-8748-7AE6FEEE9B9C

P3181

Q29619873-168FB346-4A59-42C3-A4E8-72EE94FAC4BB

P356

Q29619873-CBA68797-8CA8-4843-9BE8-6717F4AFFF05

P407

Q29619873-20051F3F-270A-4495-A091-B32D2BDFC1E8

P433

Q29619873-ADBD695E-2329-4B65-A66A-3DE438A88C69

P478

Q29619873-4AE15EB6-B4B6-4916-A111-B32E139058A8

P577

Q29619873-02E2C3D3-978B-4CA4-8E30-132D9935B12C

P5875

Q29619873-7F9301FE-FE54-49A3-B91D-0B8873F21B6F

P698

Q29619873-9B4DEF78-C29E-4156-9EC9-3109583516EF

P921

Q29619873-882931F0-1A6D-4646-8684-EFD89A6D0542

Q29619873-E81B1188-97E8-404B-B5C1-E91E43167289

P932

Q29619873-FD1AD420-C4E6-42E2-946F-E510044C1895

P3181

P356

PNAS.0805038105

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Dysregulation of microRNAs aft ...... of miR-29 in cardiac fibrosis

@en

P2093

DiMaio JM

http://www.w3.org/2001/XMLSchema#string

Hill JA

http://www.w3.org/2001/XMLSchema#string

Marshall WS

http://www.w3.org/2001/XMLSchema#string

Naseem RH

http://www.w3.org/2001/XMLSchema#string

Olson EN

http://www.w3.org/2001/XMLSchema#string

Sutherland LB

http://www.w3.org/2001/XMLSchema#string

Thatcher JE

http://www.w3.org/2001/XMLSchema#string

van Rooij E

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

Cellular and molecular mechanisms of fibrosis

A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure

Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy

Silencing of microRNAs in vivo with 'antagomirs'

MicroRNAs: genomics, biogenesis, mechanism, and function

MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins.

Transforming growth factor beta in tissue fibrosis

Phylogenetic shadowing and computational identification of human microRNA genes

Enhanced expression of fibrillin-1, a constituent of the myocardial extracellular matrix in fibrosis

P304

13027-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

189276

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.0805038105

http://www.w3.org/2001/XMLSchema#string

P407

P433

35

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23190530

http://www.w3.org/2001/XMLSchema#string

P698

18723672

http://www.w3.org/2001/XMLSchema#string

P921

P932

2529064

http://www.w3.org/2001/XMLSchema#string